I am not a statistician. I am a consumer of statistics courses from undergraduate, graduate, and post-graduate studies. I possess a theoretical grasp of numeracy that still allows a never-ending pipeline of questions and scientific inquiry.
I am unable to think of one post-graduate course that hasn't become out-dated. A dusty PhD in an obscure biological subspecialty may gain entry but my expertise in population genetics would be a relic--if I wan't continually learning...
I have mentioned the fire-hose of data and information--let's try to find a story in the numbers.
I like to use art as an interdisciplinary tool when working with clinical data and numeracy. I notice colleagues don't want to raise their hands to admit they don't understand hazard ratios or calculating number needed to treat (NNT)--but will scrunch up their faces and ask questions about what they observe in art.
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE Trial
CONCLUSIONS In patients with type 2 diabetes and a recent ACS, the risk of CV death was higher after a postrandomization, nonfatal CV event, particularly heart failure, compared with those who did not experience a CV event. The risk of CV death was similar between alogliptin and placebo.